Private Equity Archives - Gilde Healthcare

Menu
Menu
Home

latest news
Private Equity

Gilde Healthcare Acquires Sanquin Reagents

The specialized private equity fund invests in scaling-up production and development of new medical tests
August 29, 2022

Gilde Healthcare bolsters its Private Equity team in Frankfurt office

test Dutch sector specialist Gilde Healthcare announces two new hires to its private equity team in Germany, following the recent close of its new €518m lower mid-market fund Gilde Healthcare Private Equity IV. With the recruitment of Martin von Berg as Investment Manager and Lara Hilgert as Investment Analyst, the firm continues to expand its team […]

Gilde Healthcare company Zetacom acquires communication specialist Ooperon

test Dutch communication system integrator Zetacom B.V. announced the acquisition of communication specialist Ooperon B.V.

Gilde Healthcare invests in German precision surgical instruments contract manufacturer Chr. Diener

Leading contract manufacturer of highly complex, customer-specific, surgical instruments partners with Gilde Healthcare to further build on the company’s 122-year heritage.

Gilde Healthcare portfolio company Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics to expand bioanalysis capabilities in clinical drug development

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions and specifically solutions for targeted radiopharmaceuticals.

Gilde Healthcare raises more than €500 million for private equity investments in European healthcare companies

Gilde Healthcare Private Equity IV raises €517 million for investments in healthcare companies in the lower mid-market in Northwest Europe Gilde Healthcare has raised €933 million ($1.0 billion) in two years for its private equity and transatlantic venture&growth funds Gilde Healthcare today announces it raised €517 million...

The Private Equity fund of Gilde Healthcare acquires medtech contract manufacturer EUROPIN

Combination with portfolio company Acti-Med creates joint group representing one of the largest contract manufacturers of raw cannulas and cannula systems in Europe The acquisition of EUROPIN represents a major step for Gilde Healthcare in forming a leading integrated contract manufacturer for tailor-made cannulas and cannula systems,...

Gilde Healthcare Private Equity as part of Investor Consortium acquires DETAX

Specialist for medical polymer materials DETAX resolves ownership succession in the course of a management buy-out and continues its successful growth track together with a strong Investor Consortium  ·    DETAX is a leading global supplier of biocompatible silicones and light-curing 3D resins for medical applications in the...

Gilde Healthcare’s Private Equity fund sells majority stake in European CRO/CDMO Symeres to Keensight Capital

Keensight Capital, one of the principal private equity managers dedicated to pan-European Growth Buyout1 investments, has reached an agreement to invest alongside management in Symeres, a leading European drug discovery Contract Research Organization (CRO) and Contract Development and Manufacturing Organization (CDMO). According to the terms of the...
Loading...
These were all messages
f796b7e0cb